• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BOD 0.00% 2.4¢

BOD SCIENCE LIMITED - Announcements

Bod Science Limited is an Australia-based cannabis focused drug development and product... Bod Science Limited is an Australia-based cannabis focused drug development and product innovation company. The Company is focused on progressing research and development with a defined clinical trial pathway to commercialize and deliver products for consumer and medical markets. The principal activities of the Company are the development and distribution of therapeutic medicinal cannabis products based on good manufacturing practice (GMP) certified cannabis extracts for medical markets in Australia and the United Kingdom, as well as the development of cannabidiol (CBD) and hemp products for consumer markets in Australia, the United Kingdom, Europe, and United States. The Company’s segments include medical, over the counter cannabidiol/Hemp (OTC CBD/Hemp) and OTC Herbals. The Company offers products for health and wellness, joint/muscle pain and general wellbeing, and stress/anxiety and sleep. The Company also owns the Aqua Phase delivery technology.More

Announcements


Filters [Clear]
  • Price Sensitive: Yes
BOD Entry into Deed of Company ArrangementPRICE SENSITIVE26/04/24 download Created with Sketch. 240.67KB
BOD Quarterly Activities Report / Appendix 4CPRICE SENSITIVE24/04/24 download Created with Sketch. 1.17MB
BOD Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE30/01/24 download Created with Sketch. 643.56KB
BOD Extension of Convening Period for 2nd Meeting of CreditorsPRICE SENSITIVE15/12/23 download Created with Sketch. 587.14KB
BOD Medicinal cannabis supply agreement with Green FarmersPRICE SENSITIVE13/12/23 download Created with Sketch. 261.39KB
BOD Appointment of Voluntary AdministratorsPRICE SENSITIVE29/11/23 download Created with Sketch. 216.54KB
BOD Suspension from QuotationPRICE SENSITIVE28/11/23 download Created with Sketch. 115.31KB
BOD Trading HaltPRICE SENSITIVE24/11/23 download Created with Sketch. 121.76KB
BOD Bod receives $1.645m R&D Tax RebatePRICE SENSITIVE22/11/23 download Created with Sketch. 273.06KB
BOD Capital Raise UpdatePRICE SENSITIVE21/11/23 download Created with Sketch. 239.02KB
BOD Investor PresentationPRICE SENSITIVE08/11/23 download Created with Sketch. 7.43MB
BOD Reinstatement to Official QuotationPRICE SENSITIVE08/11/23 download Created with Sketch. 87.21KB
BOD Bod Science announces placement to raise A$2mPRICE SENSITIVE08/11/23 download Created with Sketch. 295.39KB
BOD Continuation of Suspension from QuotationPRICE SENSITIVE02/11/23 download Created with Sketch. 118.22KB
BOD Suspension from QuotationPRICE SENSITIVE01/11/23 download Created with Sketch. 92.18KB
BOD Appendix 4CPRICE SENSITIVE31/10/23 download Created with Sketch. 214.08KB
BOD Quarterly Activities ReportPRICE SENSITIVE31/10/23 download Created with Sketch. 289.58KB
BOD Aqua Phase CBD PK Study ResultsPRICE SENSITIVE27/09/23 download Created with Sketch. 277.83KB
BOD Schedule 3 CBD trial preliminary resultsPRICE SENSITIVE06/09/23 download Created with Sketch. 307.9KB
BOD Trading HaltPRICE SENSITIVE04/09/23 download Created with Sketch. 121.72KB
BOD FY23 Appendix 4E and Financial StatementsPRICE SENSITIVE30/08/23 download Created with Sketch. 950.21KB
BOD Bod completes acquisition of Aqua PhasePRICE SENSITIVE10/08/23 download Created with Sketch. 283.17KB
BOD Capital Raising Investor PresentationPRICE SENSITIVE03/08/23 download Created with Sketch. 8.01MB
BOD Bod announces placement to raise $1.9mPRICE SENSITIVE03/08/23 download Created with Sketch. 285.66KB
BOD Trading HaltPRICE SENSITIVE01/08/23 download Created with Sketch. 116.68KB
BOD Appendix 4CPRICE SENSITIVE31/07/23 download Created with Sketch. 1.07MB
BOD Quarterly Activities ReportPRICE SENSITIVE31/07/23 download Created with Sketch. 372.76KB
BOD Completion of Pivotal Aqua Phase PK StudiesPRICE SENSITIVE25/07/23 download Created with Sketch. 238.91KB
BOD Phase IIB Clinical Trial of Schedule 3PRICE SENSITIVE10/07/23 download Created with Sketch. 225.29KB
BOD Updates on Phase IIB clinical trial of Schedule 3 CBDPRICE SENSITIVE03/07/23 download Created with Sketch. 231.83KB
BOD Bod announces progress in Aqua Phase PK StudiesPRICE SENSITIVE30/06/23 download Created with Sketch. 304.64KB
BOD BOD and Malaysian Antah Group sign Letter of IntentPRICE SENSITIVE21/06/23 download Created with Sketch. 335.93KB
BOD Updates regarding Aqua Phase Delivery TechnologyPRICE SENSITIVE23/05/23 download Created with Sketch. 228.88KB
BOD Quarterly Activities Report and Appendix 4CPRICE SENSITIVE28/04/23 download Created with Sketch. 691.75KB
BOD Update on acquisition of Aqua PhasePRICE SENSITIVE07/03/23 download Created with Sketch. 219.71KB
BOD Bod Science establishes R&D funding facilityPRICE SENSITIVE06/03/23 download Created with Sketch. 200.35KB
BOD Appendix 4D and Half Year AccountPRICE SENSITIVE24/02/23 download Created with Sketch. 1004.31KB
BOD Quarterly Activities Report and Appendix 4CPRICE SENSITIVE31/01/23 download Created with Sketch. 707.44KB
BOD Bod Science receives $1.512 million R&D tax rebatePRICE SENSITIVE20/12/22 download Created with Sketch. 212.3KB
BOD Bod secures licensing and supply agreement with ArrotexPRICE SENSITIVE02/12/22 download Created with Sketch. 272.81KB
BOD Bod Softgel offers outstanding bioavailabilityPRICE SENSITIVE22/11/22 download Created with Sketch. 239.09KB
BOD Quarterly Activities Report and Appendix 4CPRICE SENSITIVE27/10/22 download Created with Sketch. 442.49KB
BOD Successful completion of Entitlement OfferPRICE SENSITIVE04/10/22 download Created with Sketch. 208.81KB
BOD Investor PresentationPRICE SENSITIVE01/09/22 download Created with Sketch. 4.64MB
BOD Capital raising and transformational acquisitionPRICE SENSITIVE01/09/22 download Created with Sketch. 291.49KB
BOD Appendix 4E and full year statutory accountsPRICE SENSITIVE30/08/22 download Created with Sketch. 1.33MB
BOD Bod to acquire Aqua PhasePRICE SENSITIVE30/08/22 download Created with Sketch. 200.21KB
BOD Trading HaltPRICE SENSITIVE30/08/22 download Created with Sketch. 281.01KB
BOD Bod awarded US Hemp Authority certificate for CBD extractPRICE SENSITIVE19/08/22 download Created with Sketch. 217.92KB
BOD Quarterly activities report and Appendix 4CPRICE SENSITIVE28/07/22 download Created with Sketch. 437.86KB
BOD CBD Schedule 3 product to be launched via SAS-B channelPRICE SENSITIVE23/06/22 download Created with Sketch. 216.32KB
BOD Study highlights efficacy of new medicinal cannabis productPRICE SENSITIVE25/05/22 download Created with Sketch. 227.45KB
BOD Quarterly Activities Report and Appendix 4CPRICE SENSITIVE29/04/22 download Created with Sketch. 434.28KB
BOD Half Year Activities ReportPRICE SENSITIVE25/02/22 download Created with Sketch. 248.63KB
BOD Half Year Accounts and Appendix 4DPRICE SENSITIVE25/02/22 download Created with Sketch. 663.78KB
BOD Novel food application accepted by UK Food Service AgencyPRICE SENSITIVE21/02/22 download Created with Sketch. 220.5KB
BOD Quarterly Activities Report and Quarterly Cash Flow ReportPRICE SENSITIVE31/01/22 download Created with Sketch. 432.35KB
BOD Ethics approval received for Schedule 3 clinical trialPRICE SENSITIVE24/01/22 download Created with Sketch. 234.22KB
BOD Authorisation secured for UK based long covid clinical trialPRICE SENSITIVE17/01/22 download Created with Sketch. 260.31KB
BOD Quarterly Activities Report and Appendix 4CPRICE SENSITIVE27/10/21 download Created with Sketch. 435.31KB
BOD BOD to conduct Schedule 3 clinical trial of new CBD productPRICE SENSITIVE22/09/21 download Created with Sketch. 232.32KB
BOD Record revenue achieved during FY2021PRICE SENSITIVE23/08/21 download Created with Sketch. 149.88KB
BOD Appendix 4E and Full Year Statutory AccountsPRICE SENSITIVE23/08/21 download Created with Sketch. 1.17MB
BOD Quarterly Activities Report and Appendix 4CPRICE SENSITIVE15/07/21 download Created with Sketch. 716.19KB
BOD 212% increase in medicinal cannabis product sales in FY2021PRICE SENSITIVE01/07/21 download Created with Sketch. 603.42KB
BOD Bod broadens UK sales footprintPRICE SENSITIVE17/06/21 download Created with Sketch. 692.49KB
BOD Launch of new medicinal cannabis product and UK updatePRICE SENSITIVE18/05/21 download Created with Sketch. 607.79KB
BOD Highest ever monthly sales of medicinal cannabis productsPRICE SENSITIVE10/05/21 download Created with Sketch. 571.35KB
BOD Quarterly acitivities report and Appendix 4CPRICE SENSITIVE22/04/21 download Created with Sketch. 905.25KB
BOD Bod secures first binding purchase order for US marketPRICE SENSITIVE07/04/21 download Created with Sketch. 537.77KB
BOD Record medicinal cannabis sales achieved during Q3 FY2021PRICE SENSITIVE31/03/21 download Created with Sketch. 597.89KB
BOD Strong half driven by international expansionPRICE SENSITIVE25/02/21 download Created with Sketch. 602.96KB
BOD Half Year Accounts and Appendix 4DPRICE SENSITIVE25/02/21 download Created with Sketch. 2MB
BOD Quarterly Activities Report and Appendix 4CPRICE SENSITIVE28/01/21 download Created with Sketch. 756.88KB
BOD Bod delivers record attributable sales in Q2 FY2021PRICE SENSITIVE18/01/21 download Created with Sketch. 539.96KB
BOD Bod achieves strong second half medicinal cannabis salesPRICE SENSITIVE07/01/21 download Created with Sketch. 566.84KB
BOD $871,413 in binding orders secured for the Italian marketPRICE SENSITIVE22/12/20 download Created with Sketch. 533.45KB
BOD Medical advisory board formed to capitalise on TGA decisionPRICE SENSITIVE16/12/20 download Created with Sketch. 556.6KB
BOD Proposed issue of Securities - BDAPRICE SENSITIVE11/12/20 download Created with Sketch. 25.23KB
BOD Bod secures commitments to raise $8m via private placementPRICE SENSITIVE11/12/20 download Created with Sketch. 519.91KB
BOD Trading HaltPRICE SENSITIVE10/12/20 download Created with Sketch. 561.12KB
BOD Bod to benefit from US push to decriminalise cannabisPRICE SENSITIVE07/12/20 download Created with Sketch. 533.91KB
BOD Bod to benefit from UN decision to reclassify cannabisPRICE SENSITIVE04/12/20 download Created with Sketch. 527.24KB
BOD Bod broadens European footprint with binding purchase orderPRICE SENSITIVE03/12/20 download Created with Sketch. 538.87KB
BOD $1m binding purchase order received for Italian market entryPRICE SENSITIVE24/11/20 download Created with Sketch. 538.71KB
BOD Strong growth in medicinal cannabis sales continuesPRICE SENSITIVE17/11/20 download Created with Sketch. 530.31KB
BOD Bod launches CBD products in the NetherlandsPRICE SENSITIVE20/10/20 download Created with Sketch. 533.14KB
BOD Quarterly Activities Report and Appendix 4CPRICE SENSITIVE14/10/20 download Created with Sketch. 806.99KB
BOD Record medicinal cannabis purchase orders achieved in Q1PRICE SENSITIVE07/10/20 download Created with Sketch. 593.46KB
BOD Bod achieves 'Generally Recognised as Safe' (GRAS) statusPRICE SENSITIVE23/09/20 download Created with Sketch. 539.56KB
BOD Regulatory shift unlocks large market opportunity for BodPRICE SENSITIVE10/09/20 download Created with Sketch. 539.5KB
BOD Strategic agreement to streamline UK cannabis prescriptionsPRICE SENSITIVE01/09/20 download Created with Sketch. 540.72KB
BOD Financial year 2020 results presentationPRICE SENSITIVE21/08/20 download Created with Sketch. 2.59MB
BOD Record FY2020 financial result positions Bod for growthPRICE SENSITIVE21/08/20 download Created with Sketch. 577.83KB
BOD Appendix 4E and full year statutory accountsPRICE SENSITIVE21/08/20 download Created with Sketch. 1.23MB
BOD Quarterly Activities Report and Appendix 4CPRICE SENSITIVE21/07/20 download Created with Sketch. 833.58KB
BOD Australia-wide medicinal cannabis study commencedPRICE SENSITIVE16/07/20 download Created with Sketch. 483.03KB
BOD Bod delivers record fourth quarter revenue of $2.5 millionPRICE SENSITIVE02/07/20 download Created with Sketch. 540.36KB
BOD Bod continues to achieve strong revenue growth in FY2020PRICE SENSITIVE04/06/20 download Created with Sketch. 496.95KB
BOD Continued upward trajectory in prescription volumesPRICE SENSITIVE20/05/20 download Created with Sketch. 557.32KB
BOD Entry into Deed of Company Arrangement
26/04/24PRICE SENSITIVE download Created with Sketch. 240.67KB
BOD Quarterly Activities Report / Appendix 4C
24/04/24PRICE SENSITIVE download Created with Sketch. 1.17MB
BOD Quarterly Activities/Appendix 4C Cash Flow Report
30/01/24PRICE SENSITIVE download Created with Sketch. 643.56KB
BOD Extension of Convening Period for 2nd Meeting of Creditors
15/12/23PRICE SENSITIVE download Created with Sketch. 587.14KB
BOD Medicinal cannabis supply agreement with Green Farmers
13/12/23PRICE SENSITIVE download Created with Sketch. 261.39KB
BOD Appointment of Voluntary Administrators
29/11/23PRICE SENSITIVE download Created with Sketch. 216.54KB
BOD Suspension from Quotation
28/11/23PRICE SENSITIVE download Created with Sketch. 115.31KB
BOD Trading Halt
24/11/23PRICE SENSITIVE download Created with Sketch. 121.76KB
BOD Bod receives $1.645m R&D Tax Rebate
22/11/23PRICE SENSITIVE download Created with Sketch. 273.06KB
BOD Capital Raise Update
21/11/23PRICE SENSITIVE download Created with Sketch. 239.02KB
BOD Investor Presentation
08/11/23PRICE SENSITIVE download Created with Sketch. 7.43MB
BOD Reinstatement to Official Quotation
08/11/23PRICE SENSITIVE download Created with Sketch. 87.21KB
BOD Bod Science announces placement to raise A$2m
08/11/23PRICE SENSITIVE download Created with Sketch. 295.39KB
BOD Continuation of Suspension from Quotation
02/11/23PRICE SENSITIVE download Created with Sketch. 118.22KB
BOD Suspension from Quotation
01/11/23PRICE SENSITIVE download Created with Sketch. 92.18KB
BOD Appendix 4C
31/10/23PRICE SENSITIVE download Created with Sketch. 214.08KB
BOD Quarterly Activities Report
31/10/23PRICE SENSITIVE download Created with Sketch. 289.58KB
BOD Aqua Phase CBD PK Study Results
27/09/23PRICE SENSITIVE download Created with Sketch. 277.83KB
BOD Schedule 3 CBD trial preliminary results
06/09/23PRICE SENSITIVE download Created with Sketch. 307.9KB
BOD Trading Halt
04/09/23PRICE SENSITIVE download Created with Sketch. 121.72KB
BOD FY23 Appendix 4E and Financial Statements
30/08/23PRICE SENSITIVE download Created with Sketch. 950.21KB
BOD Bod completes acquisition of Aqua Phase
10/08/23PRICE SENSITIVE download Created with Sketch. 283.17KB
BOD Capital Raising Investor Presentation
03/08/23PRICE SENSITIVE download Created with Sketch. 8.01MB
BOD Bod announces placement to raise $1.9m
03/08/23PRICE SENSITIVE download Created with Sketch. 285.66KB
BOD Trading Halt
01/08/23PRICE SENSITIVE download Created with Sketch. 116.68KB
BOD Appendix 4C
31/07/23PRICE SENSITIVE download Created with Sketch. 1.07MB
BOD Quarterly Activities Report
31/07/23PRICE SENSITIVE download Created with Sketch. 372.76KB
BOD Completion of Pivotal Aqua Phase PK Studies
25/07/23PRICE SENSITIVE download Created with Sketch. 238.91KB
BOD Phase IIB Clinical Trial of Schedule 3
10/07/23PRICE SENSITIVE download Created with Sketch. 225.29KB
BOD Updates on Phase IIB clinical trial of Schedule 3 CBD
03/07/23PRICE SENSITIVE download Created with Sketch. 231.83KB
BOD Bod announces progress in Aqua Phase PK Studies
30/06/23PRICE SENSITIVE download Created with Sketch. 304.64KB
BOD BOD and Malaysian Antah Group sign Letter of Intent
21/06/23PRICE SENSITIVE download Created with Sketch. 335.93KB
BOD Updates regarding Aqua Phase Delivery Technology
23/05/23PRICE SENSITIVE download Created with Sketch. 228.88KB
BOD Quarterly Activities Report and Appendix 4C
28/04/23PRICE SENSITIVE download Created with Sketch. 691.75KB
BOD Update on acquisition of Aqua Phase
07/03/23PRICE SENSITIVE download Created with Sketch. 219.71KB
BOD Bod Science establishes R&D funding facility
06/03/23PRICE SENSITIVE download Created with Sketch. 200.35KB
BOD Appendix 4D and Half Year Account
24/02/23PRICE SENSITIVE download Created with Sketch. 1004.31KB
BOD Quarterly Activities Report and Appendix 4C
31/01/23PRICE SENSITIVE download Created with Sketch. 707.44KB
BOD Bod Science receives $1.512 million R&D tax rebate
20/12/22PRICE SENSITIVE download Created with Sketch. 212.3KB
BOD Bod secures licensing and supply agreement with Arrotex
02/12/22PRICE SENSITIVE download Created with Sketch. 272.81KB
BOD Bod Softgel offers outstanding bioavailability
22/11/22PRICE SENSITIVE download Created with Sketch. 239.09KB
BOD Quarterly Activities Report and Appendix 4C
27/10/22PRICE SENSITIVE download Created with Sketch. 442.49KB
BOD Successful completion of Entitlement Offer
04/10/22PRICE SENSITIVE download Created with Sketch. 208.81KB
BOD Investor Presentation
01/09/22PRICE SENSITIVE download Created with Sketch. 4.64MB
BOD Capital raising and transformational acquisition
01/09/22PRICE SENSITIVE download Created with Sketch. 291.49KB
BOD Appendix 4E and full year statutory accounts
30/08/22PRICE SENSITIVE download Created with Sketch. 1.33MB
BOD Bod to acquire Aqua Phase
30/08/22PRICE SENSITIVE download Created with Sketch. 200.21KB
BOD Trading Halt
30/08/22PRICE SENSITIVE download Created with Sketch. 281.01KB
BOD Bod awarded US Hemp Authority certificate for CBD extract
19/08/22PRICE SENSITIVE download Created with Sketch. 217.92KB
BOD Quarterly activities report and Appendix 4C
28/07/22PRICE SENSITIVE download Created with Sketch. 437.86KB
BOD CBD Schedule 3 product to be launched via SAS-B channel
23/06/22PRICE SENSITIVE download Created with Sketch. 216.32KB
BOD Study highlights efficacy of new medicinal cannabis product
25/05/22PRICE SENSITIVE download Created with Sketch. 227.45KB
BOD Quarterly Activities Report and Appendix 4C
29/04/22PRICE SENSITIVE download Created with Sketch. 434.28KB
BOD Half Year Activities Report
25/02/22PRICE SENSITIVE download Created with Sketch. 248.63KB
BOD Half Year Accounts and Appendix 4D
25/02/22PRICE SENSITIVE download Created with Sketch. 663.78KB
BOD Novel food application accepted by UK Food Service Agency
21/02/22PRICE SENSITIVE download Created with Sketch. 220.5KB
BOD Quarterly Activities Report and Quarterly Cash Flow Report
31/01/22PRICE SENSITIVE download Created with Sketch. 432.35KB
BOD Ethics approval received for Schedule 3 clinical trial
24/01/22PRICE SENSITIVE download Created with Sketch. 234.22KB
BOD Authorisation secured for UK based long covid clinical trial
17/01/22PRICE SENSITIVE download Created with Sketch. 260.31KB
BOD Quarterly Activities Report and Appendix 4C
27/10/21PRICE SENSITIVE download Created with Sketch. 435.31KB
BOD BOD to conduct Schedule 3 clinical trial of new CBD product
22/09/21PRICE SENSITIVE download Created with Sketch. 232.32KB
BOD Record revenue achieved during FY2021
23/08/21PRICE SENSITIVE download Created with Sketch. 149.88KB
BOD Appendix 4E and Full Year Statutory Accounts
23/08/21PRICE SENSITIVE download Created with Sketch. 1.17MB
BOD Quarterly Activities Report and Appendix 4C
15/07/21PRICE SENSITIVE download Created with Sketch. 716.19KB
BOD 212% increase in medicinal cannabis product sales in FY2021
01/07/21PRICE SENSITIVE download Created with Sketch. 603.42KB
BOD Bod broadens UK sales footprint
17/06/21PRICE SENSITIVE download Created with Sketch. 692.49KB
BOD Launch of new medicinal cannabis product and UK update
18/05/21PRICE SENSITIVE download Created with Sketch. 607.79KB
BOD Highest ever monthly sales of medicinal cannabis products
10/05/21PRICE SENSITIVE download Created with Sketch. 571.35KB
BOD Quarterly acitivities report and Appendix 4C
22/04/21PRICE SENSITIVE download Created with Sketch. 905.25KB
BOD Bod secures first binding purchase order for US market
07/04/21PRICE SENSITIVE download Created with Sketch. 537.77KB
BOD Record medicinal cannabis sales achieved during Q3 FY2021
31/03/21PRICE SENSITIVE download Created with Sketch. 597.89KB
BOD Strong half driven by international expansion
25/02/21PRICE SENSITIVE download Created with Sketch. 602.96KB
BOD Half Year Accounts and Appendix 4D
25/02/21PRICE SENSITIVE download Created with Sketch. 2MB
BOD Quarterly Activities Report and Appendix 4C
28/01/21PRICE SENSITIVE download Created with Sketch. 756.88KB
BOD Bod delivers record attributable sales in Q2 FY2021
18/01/21PRICE SENSITIVE download Created with Sketch. 539.96KB
BOD Bod achieves strong second half medicinal cannabis sales
07/01/21PRICE SENSITIVE download Created with Sketch. 566.84KB
BOD $871,413 in binding orders secured for the Italian market
22/12/20PRICE SENSITIVE download Created with Sketch. 533.45KB
BOD Medical advisory board formed to capitalise on TGA decision
16/12/20PRICE SENSITIVE download Created with Sketch. 556.6KB
BOD Proposed issue of Securities - BDA
11/12/20PRICE SENSITIVE download Created with Sketch. 25.23KB
BOD Bod secures commitments to raise $8m via private placement
11/12/20PRICE SENSITIVE download Created with Sketch. 519.91KB
BOD Trading Halt
10/12/20PRICE SENSITIVE download Created with Sketch. 561.12KB
BOD Bod to benefit from US push to decriminalise cannabis
07/12/20PRICE SENSITIVE download Created with Sketch. 533.91KB
BOD Bod to benefit from UN decision to reclassify cannabis
04/12/20PRICE SENSITIVE download Created with Sketch. 527.24KB
BOD Bod broadens European footprint with binding purchase order
03/12/20PRICE SENSITIVE download Created with Sketch. 538.87KB
BOD $1m binding purchase order received for Italian market entry
24/11/20PRICE SENSITIVE download Created with Sketch. 538.71KB
BOD Strong growth in medicinal cannabis sales continues
17/11/20PRICE SENSITIVE download Created with Sketch. 530.31KB
BOD Bod launches CBD products in the Netherlands
20/10/20PRICE SENSITIVE download Created with Sketch. 533.14KB
BOD Quarterly Activities Report and Appendix 4C
14/10/20PRICE SENSITIVE download Created with Sketch. 806.99KB
BOD Record medicinal cannabis purchase orders achieved in Q1
07/10/20PRICE SENSITIVE download Created with Sketch. 593.46KB
BOD Bod achieves 'Generally Recognised as Safe' (GRAS) status
23/09/20PRICE SENSITIVE download Created with Sketch. 539.56KB
BOD Regulatory shift unlocks large market opportunity for Bod
10/09/20PRICE SENSITIVE download Created with Sketch. 539.5KB
BOD Strategic agreement to streamline UK cannabis prescriptions
01/09/20PRICE SENSITIVE download Created with Sketch. 540.72KB
BOD Financial year 2020 results presentation
21/08/20PRICE SENSITIVE download Created with Sketch. 2.59MB
BOD Record FY2020 financial result positions Bod for growth
21/08/20PRICE SENSITIVE download Created with Sketch. 577.83KB
BOD Appendix 4E and full year statutory accounts
21/08/20PRICE SENSITIVE download Created with Sketch. 1.23MB
BOD Quarterly Activities Report and Appendix 4C
21/07/20PRICE SENSITIVE download Created with Sketch. 833.58KB
BOD Australia-wide medicinal cannabis study commenced
16/07/20PRICE SENSITIVE download Created with Sketch. 483.03KB
BOD Bod delivers record fourth quarter revenue of $2.5 million
02/07/20PRICE SENSITIVE download Created with Sketch. 540.36KB
BOD Bod continues to achieve strong revenue growth in FY2020
04/06/20PRICE SENSITIVE download Created with Sketch. 496.95KB
BOD Continued upward trajectory in prescription volumes
20/05/20PRICE SENSITIVE download Created with Sketch. 557.32KB
(20min delay)
Last
2.4¢
Change
0.000(0.00%)
Mkt cap ! $4.256M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
BOD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.